An LSD-Based Anxiety Drug Met Its Goal in a First Late-Stage Trial, and the Road to a Prescription Is Still Long
Definium says a single dose of its LSD tablet cut anxiety scores by 5.4 points more than placebo at 12 weeks in a 214-person Phase 3 trial.
Medical Daily ·